Found: 29
Select item for more details and to access through your institution.
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
- Published in:
- Urologia Internationalis, 2023, v. 107, n. 10-12, p. 949, doi. 10.1159/000534486
- By:
- Publication type:
- Article
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction.
- Published in:
- Urologia Internationalis, 2022, v. 106, n. 10, p. 1041, doi. 10.1159/000520705
- By:
- Publication type:
- Article
How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience.
- Published in:
- Urologia Internationalis, 2017, v. 98, n. 3, p. 262, doi. 10.1159/000447361
- By:
- Publication type:
- Article
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1796, doi. 10.3390/cells10071796
- By:
- Publication type:
- Article
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1315, doi. 10.3390/cells10061315
- By:
- Publication type:
- Article
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 159, doi. 10.3390/cells10010159
- By:
- Publication type:
- Article
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer.
- Published in:
- BJU International, 2019, v. 123, n. 1, p. 187, doi. 10.1111/bju.14525
- By:
- Publication type:
- Article
C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 12, p. 1, doi. 10.1002/cti2.1358
- By:
- Publication type:
- Article
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-35637-4
- By:
- Publication type:
- Article
mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3396, doi. 10.3390/ijms19113396
- By:
- Publication type:
- Article
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.
- Published in:
- Genes, 2021, v. 12, n. 2, p. 230, doi. 10.3390/genes12020230
- By:
- Publication type:
- Article
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6325, doi. 10.3390/ijms25126325
- By:
- Publication type:
- Article
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 6567, doi. 10.2147/CMAR.S318893
- By:
- Publication type:
- Article
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 2, p. 1, doi. 10.1002/2056-4538.12369
- By:
- Publication type:
- Article
Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 11, p. 4011, doi. 10.1007/s00345-021-03788-1
- By:
- Publication type:
- Article
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 11, p. 1753, doi. 10.1007/s00345-015-1502-y
- By:
- Publication type:
- Article
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179602
- By:
- Publication type:
- Article
Patient's Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study Improve
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2830, doi. 10.3390/cancers15102830
- By:
- Publication type:
- Article
Patients Regret Their Choice of Therapy Significantly Less Frequently after Robot-Assisted Radical Prostatectomy as Opposed to Open Radical Prostatectomy: Patient-Reported Results of the Multicenter Cross-Sectional IMPROVE Study.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5356, doi. 10.3390/cancers14215356
- By:
- Publication type:
- Article
Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2850, doi. 10.3390/cancers14122850
- By:
- Publication type:
- Article
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2327, doi. 10.3390/cancers13102327
- By:
- Publication type:
- Article
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2794, doi. 10.3390/cancers12102794
- By:
- Publication type:
- Article
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1253, doi. 10.3390/cancers12051253
- By:
- Publication type:
- Article
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 994, doi. 10.3390/jcm9040994
- By:
- Publication type:
- Article
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 7, p. 642, doi. 10.3390/life11070642
- By:
- Publication type:
- Article
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial).
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42088-z
- By:
- Publication type:
- Article
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial).
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42088-z
- By:
- Publication type:
- Article
Associations of TACSTD2/TROP2 and NECTIN‐4/NECTIN‐4 with molecular subtypes, PD‐L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
- Published in:
- Histopathology, 2024, v. 84, n. 5, p. 863, doi. 10.1111/his.15130
- By:
- Publication type:
- Article